CTA Does Not Worsen Reperfusion Injury in Acute Stroke
CTA is the preferred and essential imaging modality in acute stroke and does not worsen reperfusion injury—delays in obtaining CTA are what worsen outcomes, not the imaging itself. 1
Why CTA is Safe and Essential
The concern about "worsening" stroke injury relates to time delays, not the CTA procedure itself. The 2024 American College of Radiology guidelines explicitly state that CTA of the head is the most rapid means of assessing intracranial vasculature for large vessel occlusion (LVO) and is supported by multiple randomized controlled trials as the preferred initial vascular imaging study. 1
Key Safety Points:
No direct harm from CTA: There is no evidence in the literature that the contrast administration or radiation from CTA worsens ischemic injury or reperfusion injury in stroke patients. 1
Time is the critical factor: Stroke due to LVO is a true medical emergency where the rapidity of diagnosis afforded by CTA is a strongly relevant clinical consideration—delays in diagnosis directly worsen outcomes, not the imaging itself. 1
CTA enables life-saving treatment: CTA has high sensitivity and specificity (>90%) for detecting LVO and is essential for determining eligibility for endovascular thrombectomy (EVT), which has proven benefit up to 24 hours from onset. 1
The Correct Imaging Algorithm for Right Parietal Stroke
For a patient with signs of right parietal lobe CVA:
Non-contrast CT head immediately (within 25 minutes of arrival) to exclude hemorrhage and assess ASPECTS score 1, 2
Proceed immediately to CTA head and neck if no hemorrhage is present—do not delay 1, 2
If LVO detected and <6 hours from onset: Proceed directly to EVT without additional perfusion imaging 2
If 6-24 hours from onset or unknown time: Add CT perfusion to determine salvageable tissue 1, 2
Common Pitfalls to Avoid
Never delay CTA acquisition in the acute stroke setting due to unfounded concerns about contrast "worsening" the stroke—this misconception leads to harmful delays in diagnosis and treatment. 1, 2
Do not substitute MRA for CTA in the hyperacute setting unless CTA is contraindicated (severe renal insufficiency or contrast allergy), as MRA takes longer and delays in LVO detection directly worsen outcomes. 1
Avoid delaying IV thrombolysis while obtaining CTA—these should proceed in parallel when possible, but non-contrast CT alone is sufficient to initiate thrombolysis if needed. 2
Special Circumstances
For patients with renal insufficiency or contrast allergy (the only true contraindications to CTA), use time-of-flight MRA without contrast to identify arterial occlusions and guide therapeutic decisions. 1 However, this should not be the default approach in patients without these contraindications, as it introduces time delays. 1
The contrast load from CTA is minimal compared to the potential benefit of rapid LVO detection and subsequent EVT, which can reduce mortality and severe disability by up to 80% when performed promptly. 1